CMS has awarded $8.6 million in funding to 30 states and the District of Columbia to help stabilize health insurance markets. The funding is part of $250 million earmarked for State Rate Review Grants to improve the process for how sates review proposed health insurance rates.
Several major pharmacy benefit managers (PBMs), functional middlemen that negotiate drug prices with manufacturers, say they’ve received no commitments from big drug makers to lower prices, The Hill reported.
Considering the pervasiveness of opioid misuse and abuse, people find novel avenues to access the drugs. FDA Commissioner Scott Gottlieb, MD, released a statement outlining resource guide for veterinarians to prescribe opioids for animals.
Arkansas’ Medicaid work requirements are facing major problems. During the first month of implementation in June and July, more than 5,000 residents failed to follow through on reporting that they actually worked 80 hours.
Senator Chuck Grassley, R-Iowa, has asked the U.S. Department of Justice for heightened scrutiny over two significant healthcare deals currently underway, citing limited competition and high drug pricing concerns in a letter.
A Texas lawsuit seeking a halt in the enforcement of the Affordable Care Act (ACA) is ramping up, with oral arguments scheduled for Sept. 10. The lawsuit, which was filed by 20 Republican state attorneys general, argues the ACA is unconstitutional.